Abstract
There is a continued need to develop new selective human monoamine oxidase(hMAO)inhibitors that could be beneficial for the treatment of neurological diseases.However,hMAOs are closely related with high sequence identity and structural similarity,which hinders the development of selective MAO inhibitors."Three-Dimensional Biologically Relevant Spectrum(BRS-3D)"method developed by our group has demonstrated its effectiveness in subtype selectivity studies of receptor and enzyme ligands.Here,we report a series of novel C7-substituted coumarins,either synthesized or commercially purchased,which were identified as selective hMAO inhibitors.Most of the compounds demonstrated strong activities with IC_(50)values(half-inhibitory concentration)ranging from sub-micromolar to nanomolar.Compounds,FR1 and SP1,were identified as the most selective hMAO-A inhibitors,with IC_(50)values of 1.5 nM(selectivity index(SI)<-2.82)and 19 nM(SI<-2.42),respectively.FR4 and FR5 showed the most potent hMAO-B inhibitory activity,with IC_(50)of 18 nM and 15 nM(SI>2.74 and SI>2.82).Docking calculations and molecular dynamic simulations were performed to elucidate the selectivity preference and SAR profiles.
NSTL
Mdpi